Inflammatory bowel disease research group
The Inflammatory Bowel Disease (IBD) research group is primarily focused on clinical epidemiology, prognostic research, and patient-reported outcomes research within IBD, covering both Crohn’s disease and ulcerative colitis.
Our efforts extend to organizing and conducting extensive population-based cohort studies and multicentre clinical trials alongside local interventional and quality studies. We leverage on access to nationwide patient registries for epidemiological studies and have built large IBD biobanks which form the basis of extensive translational collaboration projects.
The IBD research group has a strong clinical affiliation and maintains an expansive network of collaborators across several sectors and various research disciplines. This includes clinical trials, epidemiology, health economics, biostatistics, medical informatics, patient-reported outcomes research, microbiome studies, proteomics, metabolomics, genetics, and nutrition.
In recent years, our special emphasis has been on studying novel IBD treatment algorithms including personalized treatment approaches and shifts in IBD treatment patterns. This includes interest in the introduction and utilization of new targeted therapies, both at the local and regional levels, as well as on a national scale.
